Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,895,211
-$2,474,533 QoQ
Shares Held
1,382,699
-26.1% QoQ
Ownership
0.676%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 216 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Dec 31, 2021CallValue
$1,677,540
CallShares
146,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ANNX ranks #61 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ANNX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,895,211 | 1,382,699 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,369,744 | 1,871,795 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,863,373 | 371,190 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $274,649 | 90,049 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $88,228 | 45,714 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $28,865,463 | 5,626,796 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $31,535,828 | 5,326,998 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,346,183 | 5,989,017 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $36,971,388 | 5,156,400 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $1,775,943 | 461,284 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,877,500 | 750,000 | Shares | Defined | 2023-05-15 | |
| 2021-12-31 | $1,677,540 | 146,000 | Call | Defined | 2022-02-14 | |
| 2021-12-31 | $10,050,900 | 874,752 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,028,408 | 1,022,483 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,903,531 | 351,112 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,918,072 | 248,494 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||